Co Diagnostics Inc (CODX)

Currency in USD
0.1783
-0.0194(-9.81%)
Real-time Data·
CODX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.17540.1904
52 wk Range
0.171513.5400
Key Statistics
Prev. Close
0.1977
Open
0.1904
Day's Range
0.1754-0.1904
52 wk Range
0.1715-13.54
Volume
331.68K
Average Volume (3m)
1.99M
1-Year Change
-98.2637%
Book Value / Share
1.35
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CODX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.0000
Upside
+2,143.41%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Co Diagnostics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 4.0000
(+2,143.41% Upside)

Co Diagnostics Inc Earnings Call Summary for Q3/2026

  • Co-Diagnostics posted Q3 2026 EPS of -$1.01 vs. -$2.85 est. and revenue of $282,880 vs. $143,620 est.; shares fell 9.5% despite the beat.
  • Operating expenses declined 12% YoY to $6.2M; YTD operating cash burn improved 9.6% to $20.7M from $22.9M, reflecting cost discipline efforts.
  • Two major regulatory submissions under review: FDA filing for Flu A/B & RSV test and India CDSCO submission for TB test showing 97.3% sensitivity.
  • No formal guidance provided; management highlighted regulatory milestones and platform expansion as key drivers for upcoming quarters.
  • Stock trades near 52-week low of $0.245, down 97% over past year, as investors remain cautious on commercialization path and limited revenue scale.
Last Updated: 11/11/2026, 08:52 am
Read Full Transcript

Earnings

Latest Release
10/11/2026
EPS / Forecast
-1.01 / -2.85
Revenue / Forecast
282.88K / 143.62K
EPS Revisions
Last 90 days

CODX Income Statement

Compare CODX to Peers and Sector

Metrics to compare
CODX
Peers
Sector
Relationship
P/E Ratio
0.0x−0.3x−0.2x
PEG Ratio
0.00−0.270.00
Price/Book
0.2x2.4x2.6x
Price / LTM Sales
2.4x2.4x2.7x
Upside (Analyst Target)
-23.9%69.6%
Fair Value Upside
Unlock−3.3%11.7%Unlock

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
121.95K1.53%24.11K
Other Institutional Investors
571.38K7.19%112.96K
Public Companies & Retail Investors
7.25M91.28%1.43M
Total
7.95M100.00%1.57M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Armistice Capital LLC2.97%236,00047
Jane Street Group, LLC1.12%89,24018

People Also Watch

0.0033
SHFS
-36.84%
0.8092
AMOD
+3.36%
3.8450
NCPL
+33.05%
1.120
DKI
-1.75%
1.090
WFF
+6.82%

FAQ

What Is the Co Diagnostics (CODX) Stock Price Today?

The Co Diagnostics stock price today is 0.1783 USD.

What Stock Exchange Does Co Diagnostics Trade On?

Co Diagnostics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Co Diagnostics?

The stock symbol for Co Diagnostics is "CODX."

What Is the Co Diagnostics Market Cap?

As of today, Co Diagnostics market cap is 2.0800M USD.

What Is Co Diagnostics's Earnings Per Share (TTM)?

The Co Diagnostics EPS (TTM) is -12.86.

When Is the Next Co Diagnostics Earnings Date?

Co Diagnostics will release its next earnings report on 25/03/2027.

From a Technical Analysis Perspective, Is CODX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Co Diagnostics Stock Split?

Co Diagnostics has split 0 times.

How Many Employees Does Co Diagnostics Have?

Co Diagnostics has 115 employees.

What is the current trading status of Co Diagnostics (CODX)?

As of 19/11/2026, Co Diagnostics (CODX) is trading at a price of 0.1783 USD, with a previous close of 0.1977 USD. The stock has fluctuated within a day range of 0.1754 USD to 0.1904 USD, while its 52-week range spans from 0.1715 USD to 13.5400 USD.

What Is Co Diagnostics (CODX) Price Target According to Analysts?

The average 12-month price target for Co Diagnostics is 4.0000 USD, with a high estimate of 4 USD and a low estimate of 4 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +2,143.41% Upside potential.

What Is the CODX Premarket Price?

CODX's last pre-market stock price is 0.1900 USD. The pre-market share volume is 47,540.0000, and the stock has decreased by -0.0077, or -3.8900%.

What Is the CODX After Hours Price?

CODX's last after hours stock price is 0.1976 USD, the stock has decreased by -0.0001, or -0.0500%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.